EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Betulinic Acid Enema Alleviates Colitis by Targeting Vitamin D Receptor to Protect the Intestinal Mucosal Barrier and Modulate Mucosa‐Associated Microbiota

Lina Dong, Yuanxia Gao, Qian Li, Guangxin Chen, Dong Yang, Liping Zhao, Xiaojing Liu, Shumei Lin

Phytotherapy Research · 2026-11 · 40 (11) · 6094-6111

DOI: 10.1002/ptr.70404 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-06-18. Written by Lina Dong and 7 co-authors. Institution: Core Laboratory, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. Major MEDLINE topics: Receptors, Calcitriol, Pentacyclic Triterpenes, Intestinal Mucosa, Gastrointestinal Microbiome. 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Shanxi Provincial Basic Research Program Project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Ulcerative colitis (UC) is a chronic inflammatory disease of the colon with limited effectiveness and safety of current drug therapies. Betulinic acid (BA) is a naturally occurring pentacyclic triterpenoid present in traditional Chinese medicines used clinically as retention enemas for UC, but its direct effects and mechanisms remain unclear. This study evaluated the therapeutic impact of BA enema in dextran sulfate sodium (DSS)‐induced colitis by monitoring disease activity index (DAI), colon length, and histopathology, and by assessing inflammatory cytokines, mucosal tight junction, and mucin‐2 (MUC2) expression. Colonic mucosa‐associated microbiota were profiled by 16S rRNA gene sequencing. Potential BA targets were predicted using Swiss Target Prediction and validated by molecular docking, molecular dynamics simulations, cellular thermal shift assay, and biolayer interferometry. The functional relevance of the vitamin D receptor (VDR) was examined using a VDR antagonist in vivo and in vitro, and transcriptomic datasets from UC patients were analyzed to define VDR expression patterns. BA enema markedly attenuated DSS‐induced colitis, such as reducing the DAI, inhibiting colonic damage, and improving colon length shortening. The BA also significantly restored the tight junction proteins, associated mucin proteins, and mucin‐2 (MUC2). The BA reduced potentially pathogenic bacteria in the colonic mucosa. In addition, BA significantly restored the VDR proteins, and the VDR antagonist weakened the effects of BA in vivo and in vitro. The binding site between VDR and BA was Trp286. Transcriptomic analyses confirmed VDR downregulation in UC. These findings indicate that BA enema alleviates experimental colitis in part by targeting VDR to protect the intestinal mucosal barrier and modulate mucosa‐associated microbiota, supporting BA as a promising candidate for UC treatment.

Subjects

MeSH terms (MEDLINE)

Receptors, CalcitriolPentacyclic TriterpenesIntestinal MucosaGastrointestinal MicrobiomeColitis, UlcerativeColitisTriterpenesBetulinic AcidAnimalsEnemaHumansMaleDextran SulfateIntestinal Barrier FunctionColonMiceMucin-2Molecular Docking SimulationMice, Inbred C57BL

Author keywords

VDRbetulinic acidintestinal barriermicrobiotaulcerative colitis

Substances

Betulinic AcidReceptors, CalcitriolPentacyclic TriterpenesDextran SulfateMucin-2Triterpenes

Authors and institutions

  • Core Laboratory, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  • Department of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
  • Institutes of Biomedical Sciences, Shanxi University, Taiyuan, Shanxi, People's Republic of China.
  • Clinical Laboratory, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
  • Department of Pathology, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.

Funding

  • Shanxi Provincial Basic Research Program Project

Cite

APA

Dong, L., Gao, Y., Li, Q., Chen, G., Yang, D., Zhao, L., Liu, X., & Lin, S. (2026). Betulinic Acid Enema Alleviates Colitis by Targeting Vitamin D Receptor to Protect the Intestinal Mucosal Barrier and Modulate Mucosa‐Associated Microbiota. Phytotherapy Research, 40(11), 6094-6111. https://doi.org/10.1002/ptr.70404

Vancouver

Dong L, Gao Y, Li Q, Chen G, Yang D, Zhao L, et al. Betulinic Acid Enema Alleviates Colitis by Targeting Vitamin D Receptor to Protect the Intestinal Mucosal Barrier and Modulate Mucosa‐Associated Microbiota. Phytotherapy Research. 2026;40(11):6094-6111. doi:10.1002/ptr.70404

BibTeX
@article{Dong2026,
  author = {Dong, Lina and Gao, Yuanxia and Li, Qian and Chen, Guangxin and Yang, Dong and Zhao, Liping and Liu, Xiaojing and Lin, Shumei},
  title = {Betulinic Acid Enema Alleviates Colitis by Targeting Vitamin D Receptor to Protect the Intestinal Mucosal Barrier and Modulate Mucosa‐Associated Microbiota},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6094--6111},
  doi = {10.1002/ptr.70404}
}
Start for free →